UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                                 Date of Report:
                        (Date of earliest event reported)

                                 January 3, 2016


       UNITED CANNABIS CORPORATION
-------------------------------------------
(Exact name of registrant as specified in                 charter)


                   Colorado
------------------------------------------------
 (State or other Jurisdiction of Incorporation
               or Organization)


                              1600 Broadway, Suite 1600
      000-54582                    Denver, CO 80202               46-5221947
   ----------------         -----------------------------  ------------------
(Commission File Number)  (Address of Principal Executive    (IRS Employer
       Number)                  Offices and Zip Code)     Identification Number)


                                 (303) 386-7321
                  -------------------------------------------
              (Registrant's telephone number, including area code)


                                       N/A
              ----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing  obligation  of  registrant  under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
    CFR 240.14a-12(b))

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))

<PAGE>

ITEM 5.02   DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS;
            APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF
            CERTAIN OFFICERS


     On January 15, 2016, the Board of Directors awarded  1,050,000,  1,050,000,
and 9820,000  stock  options to each of its three  executive  officers,  Earnest
Blackmon, Tony Verzura and Chad Ruby, respectively.  The options have a ten year
term,  vest  immediately and the exercise price is $0.20 per share which was the
closing price of the Company's common stock on January 14, 2016.

     On January 3,  2016,  the  Company's  Board of  Directors  voted to set the
annual salary for Mr. Verzura at $48,000  effective January 1, 2016. At the same
time, Mr. Blackmon and Mr. Ruby agreed to discontinue  taking salaries effective
January 1, 2016.









                                       2
<PAGE>



                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                      UNITED CANNABIS CORPORATION


Dated:  January 19, 2016              By: /s/ Chad Ruby
                                          ------------------------------------
                                          Chad Ruby
                                          Chief Operating Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kitem502issuestk1-16.txt", "description": "FORM 8-K ITEM 5.02 ISSUE STOCK OPTIONS", "secsgml_size_bytes": 3612}]
{"company-data": {"conformed-name": "United Cannabis Corp", "cik": "0001436161", "assigned-sic": "2834", "irs-number": "261391338", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54582", "film-number": "161350258"}, "business-address": {"street1": "1600 BROADWAY", "street2": "SUITE 1600", "city": "DENVER", "state": "CO", "zip": "80202", "phone": "(407) 432-2547"}, "mail-address": {"street1": "1600 BROADWAY", "street2": "SUITE 1600", "city": "DENVER", "state": "CO", "zip": "80202"}, "former-company": {"former-conformed-name": "MySkin, Inc.", "date-changed": "20080528"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                                 Date of Report:
                        (Date of earliest event reported)

                                 January 3, 2016

       UNITED CANNABIS CORPORATION
-------------------------------------------
(Exact name of registrant as specified in                 charter)

                   Colorado
------------------------------------------------
 (State or other Jurisdiction of Incorporation
               or Organization)

                              1600 Broadway, Suite 1600
      000-54582                    Denver, CO 80202               46-5221947
   ----------------         -----------------------------  ------------------
(Commission File Number)  (Address of Principal Executive    (IRS Employer
       Number)                  Offices and Zip Code)     Identification Number)

                                 (303) 386-7321
                  -------------------------------------------
              (Registrant's telephone number, including area code)

                                       N/A
              ----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing  obligation  of  registrant  under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
    CFR 240.14a-12(b))

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))
ITEM 5.02   DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS;
            APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF
            CERTAIN OFFICERS

     On January 15, 2016, the Board of Directors awarded  1,050,000,  1,050,000,
and 9820,000  stock  options to each of its three  executive  officers,  Earnest
Blackmon, Tony Verzura and Chad Ruby, respectively.  The options have a ten year
term,  vest  immediately and the exercise price is $0.20 per share which was the
closing price of the Company's common stock on January 14, 2016.

     On January 3,  2016,  the  Company's  Board of  Directors  voted to set the
annual salary for Mr. Verzura at $48,000  effective January 1, 2016. At the same
time, Mr. Blackmon and Mr. Ruby agreed to discontinue  taking salaries effective
January 1, 2016.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                      UNITED CANNABIS CORPORATION

Dated:  January 19, 2016              By: /s/ Chad Ruby
                                          ------------------------------------
                                          Chad Ruby
                                          Chief Operating Officer